ALIMTA INJECTION 500mg vial
ALIMTA INJECTION 500mg Vial (Pemetrexed)
ALIMTA (pemetrexed) is a chemotherapy medication used to treat certain types of cancer, primarily non-small cell lung cancer and malignant pleural mesothelioma. It works by inhibiting the growth of cancer cells and slowing their spread in the body.
Indications
ALIMTA is indicated for the treatment of:
- Non-small cell lung cancer (NSCLC) after prior chemotherapy
- Malignant pleural mesothelioma
Dosage and Administration
The recommended dosage of ALIMTA is based on body surface area and must be administered under the supervision of a qualified healthcare professional. It is typically given as an intravenous infusion.
Mechanism of Action
Pemetrexed is an antifolate that inhibits multiple enzymes involved in the folate pathway, which is crucial for DNA synthesis and cell division. This action helps to prevent the growth and proliferation of cancer cells.
Side Effects
Common side effects of ALIMTA may include:
- Nausea and vomiting
- Fatigue
- Loss of appetite
- Low blood cell counts (anemia, neutropenia, thrombocytopenia)
Patients should report any severe or persistent side effects to their healthcare provider.
Precautions
Before administering ALIMTA, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. Regular monitoring of blood counts is essential during treatment.
Storage
Store ALIMTA in a refrigerator at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.
Conclusion
ALIMTA is a critical option for patients diagnosed with specific types of cancer. Its mechanism of action targets cancer cell growth, providing a vital treatment pathway for those in need. Always consult with your healthcare provider for personalized medical advice and treatment plans.
